Science Pipeline IR News Center Publications SAB About Contact

← Back to ListCompany

Woongbi launches FLIPR-based service with Molecular Devices

2022-05-20

← Back to List

RudaCure

AI-driven ion channel drug discovery platform developing non-opioid therapeutics for pain and sensory diseases.

9 Songdo Mirae-ro, Yeonsu-gu, Incheon, Korea

Tel: 032-724-9070 | Fax: 032-724-9071

sh.kim@rudacure.com

Company

Science
Pipeline
IR
News Center
Publications
SAB
About
Contact

Social

© 2026 RudaCure Co., Ltd. All rights reserved.

Redefining Pain, Restoring Sensation